Environmental, Social, And Governance Report

Overview

The report presents Legend Biotech's second ESG disclosure, covering 2024 performance and governance enhancements. It highlights more than $266 million invested in R&D and the approval of CARVYKTI® for second-line treatment in the U.S. and Europe. The report also discloses a global workforce of more than 2,600 employees and detailed energy and greenhouse-gas data, including 28,681,756 kWh of total energy consumption.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Publication date: 10 April 2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services